Pharmacogenomics of Cisplatin Sensitivity in Non-small Cell Lung Cancer
Cisplatin, a platinum-based chemotherapeutic drug, has been used for over 30 years in a wide variety of cancers with varying degrees of success. In particular, cisplatin has been used to treat late stage non-small cell lung cancer (NSCLC) as the standard of care. However, therapeutic outcomes vary f...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2014-10-01
|
| Edice: | Genomics, Proteomics & Bioinformatics |
| Témata: | |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S1672022914001090 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|